NCT01514760
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
Clinical trial condition
Lung Diseases, Obstructive
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
7,978 public trials
744 recruiting studies
Lung Diseases, Obstructive trial results
NCT01328444
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
- GSK Investigational Site Albany, New York, United States
- GSK Investigational Site Columbus, Ohio, United States
Completed
Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD
NCT02576626
- Conditions
- COPD, Chronic Disease, Disease Attributes, +10 more
- Locations
-
- UMCG Groningen, Netherlands
Completed
Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
NCT02586506
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Huntington Beach, California, United States
- GSK Investigational Site Aventura, Florida, United States
- GSK Investigational Site Miami, Florida, United States
NCT02164539
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Upland, California, United States
- GSK Investigational Site Sunset, Louisiana, United States
Completed
Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00676052
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- GSK Investigational Site Jasper, Alabama, United States
- GSK Investigational Site Glendale, Arizona, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Fullerton, California, United States
Completed
A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
NCT01730027
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Pulmagen Investigational Site Birmingham, Alabama, United States
- Pulmagen Investigational Site Huntington Beach, California, United States
- Pulmagen Investigational Site Riverside, California, United States
- Pulmagen Investigational Site Rolling Hills, California, United States
NCT02148445
- Conditions
- Behavior, Chemically-Induced Disorders, Chronic Disease, +13 more
- Locations
-
- Kansas University Medical Center Kansas City, Kansas, United States
NCT01573624
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site St Louis, Missouri, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Orangeburg, South Carolina, United States
- GSK Investigational Site Spartanburg, South Carolina, United States
Completed
Factors Influencing Pediatric Asthma
NCT03302962
- Conditions
- Asthma, Asthma in Children, Bronchial Diseases, +7 more
- Locations
-
- Missouri Breaks Industries Research Inc. Eagle Butte, South Dakota, United States